>>> TradeGate Pre-Market Indications

DAX:
  • Siemens Healthineers (SHL TH) +0.4%
  • Commerzbank (CBK TH) -0.5%
    • Commerzbank Asks BaFin to Probe UniCredit Offer Disclosures (2)
  • Siemens (SIE TH) -0.5%
  • BASF (BAS TH) -0.6%
  • Deutsche Bank (DBK TH) -0.6%
  • Infineon (IFX TH) -1.4%
    • Before the European Bell: Stocks Receive AI Reality Check
MDAX:
  • Puma (PUM TH) +3.4%
    • Puma Raised to Buy at Citi on Major China Growth Opportunity
  • Thyssenkrupp (TKA TH) -0.9%
  • Aixtron (AIXA TH) -1.5%
  • Redcare Pharmacy NV (RDC TH) -2.8%
SDAX:
  • SFC Energy (F3C TH) -1.1%
  • Verbio SE (VBK TH) -1.2%
  • Secunet Security Networks (YSN TH) -1.6%
  • Siltronic (WAF TH) -1.9%

>>> Stoxx 600 Pre-Market Indications

  • Abivax (2X1 TH) +9.5%
  • Puma (PUM TH) +2.5%
    • Puma Raised to Buy at Citi on Major China Growth Opportunity
  • Games Workshop (G7W TH) +1%
  • CSG NV (NW0 TH) +0.6%
  • Eurofins Scientific (ESF0 TH) +0.6%
  • ASM Intl (AVS TH) -1.2%
  • Prysmian (AEU TH) -1.3%
  • Veolia (VVD TH) -1.3%
  • Legal & General (LGI TH) -1.3%
  • Rio Tinto (RIO1 TH) -1.4%
  • BE Semiconductor (BSI TH) -1.5%
  • Infineon (IFX TH) -1.7%
  • Standard Chartered (STD TH) -1.9%
  • Babcock (BW3 TH) -2.2%
  • Nokia (NOA3 TH) -5%
    • Before the European Bell: Stocks Receive AI Reality Check

>>> Europe : Brokers Upgrades & Downgrades - 4th of June 2026

>>> Up
* Clas Ohlson Raised to Buy at SEB Equities; PT 425 kronor
* FLSmidth Raised to Buy at BofA
* Puma Raised to Buy at Citi; PT 35 euros
* Rockwool Raised to Buy at Nordea; PT 230 kroner
* Wartsila Raised to Neutral at Goldman; PT 34 euros

>>> Down
* Barry Callebaut Cut to Neutral at Goldman; PT 1,210 Swiss francs
* PSP Swiss Cut to Sell at Van Lanschot Kempen
* PVH Cut to Inline at Evercore ISI; PT $79

>>> Initiation
* Akzo Nobel Resumed Buy at Citi; PT 61 Swiss francs
* Oeneo Rated New Outperform at Oddo BHF; PT 11.50 euros
* Santhera Rated New Buy at Stifel; PT 25 Swiss francs
* Sylvania Platinum Rated New Outperform at RBC; PT 175 pence

>>> Call
* Defense Stocks Losing Steam as Catalysts Fade, Bernstein Says
* Oeneo Poised for Gradual Recovery, New Outperform at Oddo BHF
* Puma Raised to Buy at Citi on Major China Growth Opportunity

WSJ : Top AI CEOs Call for Law Protecting Against Biological Weapons

Top AI CEOs Call for Law Protecting Against Biological Weapons
Artificial intelligence magnifies concern that criminals could unleash new pathogens


  • Top AI executives and security experts urged Congress to require safeguards for synthetic DNA and RNA.
  • The executives signed a letter calling for companies selling synthetic nucleic acids to be required to screen customer orders.
  • President Trump signed an executive order on model oversight and cybersecurity, shifting from a hands-off approach to AI.

WASHINGTON—Top artificial-intelligence executives are joining security experts in calling for Congress to protect against biological threats posed by AI, adding to growing pressure on lawmakers to address the technology’s risks.

Three major chief executive officers—OpenAI’s Sam Altman, Anthropic’s Dario Amodei and Demis Hassabis of Google’s DeepMind AI lab—are among the signatories of a letter urging Congress to require safeguards when companies order synthetic DNA and RNA, a key step in developing certain vaccines and biotech breakthroughs.

The goal is to make companies that sell the synthetic nucleic acids screen customer orders to block any combinations that could be dangerous, and make sure the customers who place the orders are legitimate.

While the concerns are longstanding in the biotech industry, AI is magnifying them by potentially giving criminals the tools to unleash new pathogens.

“AI systems are improving rapidly, and alongside incredible benefits to science and medicine, there is a real possibility that the knowledge barriers which have historically prevented bad actors from obtaining biological weapons will meaningfully erode,” the letter says.

It was organized by two tech-focused think tanks that said the topic is a rare source of agreement among libertarians, progressives, researchers and rival executives.

The letter comes after President Trump on Tuesday signed a hotly contested executive order broadly focused on model oversight and cybersecurity, a shift from the administration’s previous hands-off approach to AI.

Altman met with White House officials and lawmakers Wednesday to discuss the company’s proposal for stronger requirements for model developers. OpenAI recently announced a new program based on its science-focused model to work with the federal government to prevent biological risks.

Altman and Amodei often disagree on AI policy, with Anthropic typically supporting stronger regulations than others in the industry. Hassabis is credited with helping Alphabet’s Google catch up in the tech race and shared the 2024 Nobel Prize for his work on an AI platform that can predict a protein’s structure and accelerate drug discovery.

Other signatories include Mustafa Suleyman, who leads Microsoft’s AI work, and Meta Platforms Chief AI Officer Alexandr Wang.

Trump previously revoked a Biden-era executive order that resulted in a gene synthesis screening framework. The White House last year said it would replace the Biden framework with its own screening guidelines but hasn’t yet published a replacement policy. A White House official said the administration is committed to balancing innovation and safety.

Proponents of the screening said Congress should pass a law so that it applies to all purchasers of synthetic nucleic acids, not just those who voluntarily screen or those receiving federal funding who are most affected by executive orders. Several bills have been proposed that include the provision, but they haven’t gained traction.

Opponents said it is subjective which combinations of nucleic acids are considered dangerous and warn that the costs of complying could hurt startups.

Those costs are worth it given the risks posed by biological weapons, said Dean Ball, a former Trump AI adviser now at the Foundation for American Innovation think tank, which helped organize the letter. “If you’re synthesizing the stuff that yields biological life and viruses, we’re asking you to screen to see whether it is dangerous in some way,” he said. “That seems like a reasonable thing for society to insist upon.”

WSJ : SoftBank CEO’s Bad Bets Left Him in Despair. An AI Spree Has Him Back on T

SoftBank CEO’s Bad Bets Left Him in Despair. An AI Spree Has Him Back on Top.
In an interview, Masayoshi Son shrugs off an AI bubble and says a correction would be a good time to invest. ‘Aim for much bigger fish.’

  • SoftBank Group became Japan’s most valuable company, ending Toyota’s 23-year reign, due to its AI investment pivot.
  • SoftBank Group plans to invest at least $52 billion in French data centers, part of its global AI spending spree.
  • SoftBank Group’s AI bets involve complex financial engineering, including a $3.1 billion loan to Son for a personal stake in an OpenAI fund.

PARIS—Billionaire tech investor Masayoshi Son was in despair three years ago—his reputation stained by bad startup bets and his company’s stock price cut in half. He told his investors he cried.

Fast forward to Monday, when Son strode out of a black Mercedes at the Élysée Palace to be fêted by Emmanuel Macron—the fourth world leader to publicly host him in the past two years.

Under ornate glass chandeliers, he boasted to cameras that his Tokyo-based technology conglomerate would unleash at least $52 billion of investment in French data centers, part of his global artificial-intelligence spending spree.

The time has come to “aim for much bigger fish,” Son said in an interview at the Ritz Paris after meeting Macron. A phalanx of Son’s aides sat nearby. “I want to be an architect for the future of mankind.”

His company, SoftBank Group 9984 -10.61%decrease; red down pointing triangle, on Monday became Japan’s most valuable, ending Toyota’s 23-year reign. Son is the country’s richest man—his SoftBank stock is worth about $100 billion, more than four times as much as a year ago.

The times of plenty are owed largely to Son’s decision to bet the SoftBank farm on AI, shifting the company from a hodgepodge of startups, telecommunications and e-commerce to a leading investor in the searing-hot sector.

SoftBank’s reach spans a $64 billion investment in OpenAI, plans for a fleet of data centers, robotics and its chip company Arm, which has surged in valuation after an AI pivot.

Helping fuel the company’s transition: a heavy dose of sophisticated financial engineering and circular transactions that have boosted SoftBank’s spending power and share price. SoftBank is one of the biggest investors in OpenAI and Arm—as well as one of the biggest customers of both companies.

SoftBank would be highly exposed if the AI frenzy falters.

Seated in a gilded salon before he met with Macron again at a conference in Versailles, Son acknowledged that a downturn in the AI market on the order of the dot-com bust “can happen any time.”

Speaking in fervent tones, he declared that “half-good guys will be all gone. Half-believers will be all gone.” He added: “True believers and true value creators survive.”

Like the internet, Son said he believes the AI revolution will only grow over the long term.

“Therefore, we don’t call it a bubble,” said Son. “It’s called evolution. Once evolution happens, it never goes back.”

Son enjoys his fortune from a newly built beaux-arts megamansion that aides compare to Versailles. It contains its own 18-hole golf course and statues of figures including Marcus Aurelius. A fan of Napoleon, Son shows off art featuring the French emperor to guests.

Born in Japan to Korean parents and educated at the University of California, Berkeley, the techno-optimist has been a leading figure in booms and busts for three decades—with his wealth and reputation whipsawing up and down with the cycles.

His style is eccentric. He has told startup founders they needed to spend more money, minutes into an initial meeting. Eschewing staid quarterly earnings presentations, he used to deliver zany slideshows that proclaimed the information revolution would bring “happiness for everyone.” In the pandemic, a slide portrayed surviving startups as winged unicorns escaping a gulch—the “Valley of Coronavirus.”

Son founded SoftBank in 1981, and through much of its history it has largely been a collection of tech investments. His first big breakout came during the dot-com boom, when internet investments made him the world’s richest man for just three days—in his words—before the bubble burst and wiped out 99% of SoftBank’s value.

He charged back thanks to an early investment in Chinese online retailer Alibaba and a debt-heavy purchase of Vodafone’s Japanese unit.

To his shareholders, he invoked Yoda, saying he used gut instinct—the force—to drive investments, including from his $100 billion Vision Fund, the largest tech vehicle ever, launched in 2017.

But Son’s gut was often wrong. Soured investments in WeWork, ride-hailing company DiDi and companies that promised robot-made pizza and Uber for dog walking were all black eyes.


By late 2022, with the tech market in the doldrums, he retreated from public appearances, and underwent a period of soul-searching.

“I was feeling that I’m getting old without enough achievement,” Son said this week. “I was wondering, why should I end my life not feeling satisfied?”

The huge advancements in generative AI, epitomized by the release of ChatGPT, shocked him into action.

Son shed vast holdings of T-Mobile, Alibaba and even Nvidia as he sought to plow money into OpenAI, data centers and robotics.

Staff who previously hunted for iconoclastic founders with promising startups were sent to find AI data-center sites, the energy needed to power them and the chips to run them.

The company’s investments in OpenAI are the largest ever in a private company, $32 billion in 2025 and a further $30 billion this year.

SoftBank’s AI bets are financially complex, use a lot of debt and often involve transactions between the company’s units or entities in which it has large stakes.

SoftBank executives play down the risks of the financing deals, saying the sums are small in the context of a company with hundreds of billions of dollars in assets.

A large chunk of the cash SoftBank has plowed into OpenAI has come from borrowing against the swelling value of SoftBank’s stake in Arm Holdings, the chip designer.

Arm in turn has benefited from SoftBank, which paid Arm $704 million in the 12 months through March for an undisclosed chip-development project. SoftBank spending accounted for 60% of Arm’s revenue growth, according to company filings.

Much of Arm’s recent stock growth came after a well-received pivot into AI-focused chip design. An Arm spokeswoman said the “vast majority of Arm’s revenue continues to come from customers outside the SoftBank ecosystem, with growth driven by broad-based demand.”


SoftBank also provides a sizable amount of OpenAI’s revenue. It agreed in early 2025 to pay OpenAI $3 billion a year for a yet-to-be-launched product called Cristal Intelligence.

SoftBank’s first announced tenant in a new data-center push is OpenAI, which signed a lease with SoftBank for a 1.2-gigawatt facility that could cost around $2 billion a year in rent, based on prevailing rates.

Son is in for a personal payday that could run into the tens of billions of dollars if OpenAI’s ascent continues. SoftBank’s board approved a loan to Son of $3.1 billion that gives him a personal stake in the fund SoftBank used to invest in OpenAI. U.S. securities law prohibits public companies from lending to CEOs, though such a deal is allowed under Japanese law.

Son gets 17.25% of profits after SoftBank receives some return on a large portion of its investment. The arrangement means that SoftBank shareholders bear most of the risk, having put up the full $139 billion of the fund.

SoftBank says in its securities filings the arrangement with Son leads to an “enhanced focus on the management of investments” in the fund, which is intended to improve SoftBank’s performance.

David Dai, an analyst at Bernstein, said some deals between SoftBank units are natural given the company’s wide reach in numerous areas of AI.

Eager to raise cash for data centers, Son plans to tap the market’s hunger for companies focused on AI and related uses by spinning off collections of companies within SoftBank. Executives are planning an initial public offering of a robotics unit, Roze AI, for June.

A separate IPO would list SB Energy, a midsize solar-power company that has become a data-center builder. SoftBank has plans in the U.S., including 10 gigawatts of data centers in Ohio next to a $33 billion gas power plant it is developing, which is funded by the U.S.-Japan trade deal.

More debt is likely to play a role, too. Son said in the interview that it will be easy to find financing for 80% or 90%—or more—of the cost of the data centers once SoftBank signs long-term agreements with big tech companies for the facilities.

“It’s a big-size investment but most of the money can come from project finance,” Son said. “We don’t have to put in a lot of our own equity.”

He is sanguine that SoftBank will be a winner from any AI shakeout, which he said could be like a typhoon or an earthquake.

The strong will “survive and then they become 10 times more powerful, 100 times more powerful. That was proved in the history of the dot-com bubble,” he said. “The survivor has grown 100x.”

>>> US After Hours Summary: AVGO -12.8%, NTSK -20.6%, PVH -19.8%, FIVE -10.8%, C

After Hours Summary: AVGO -12.8%, NTSK -20.6%, PVH -19.8%, FIVE -10.8%, CRWD -10.7% lower on earnings; ADCT -45.8% on topline data

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: TLYS +13.1%, AI +2.2%, IDT +1.8%

Companies trading higher in after hours in reaction to news: VSTM +4.4% (FDA grants Fast Track Designation for VS-7375), IOVA +3.2% (TGA of Australia grants approval with conditions of Amtagvi), ALNY +2.5% (collaboration with Inceptive Nucleics), CBOE +1.5% (reports May trading statistics), COST +1.3% (May same store comps), ZG +1.2% (authorizes additional $1.25 bln in repurchases; also amends repurchase program to limit any shareholder to 45% voting power), IPI +1.1% (increases share repurchase authorization to $50 mln from $35 mln), NDAQ +1% (reports May monthly volumes), ET +0.2% (co-CEO Marshall McCrea to retire, names new CEO), ADSK +0.2% (collaboration with Amazon Web Services)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: NTSK -20.6% (also CFO to retire), PVH -19.8%, AVGO -12.8%, WOOF -12.1%, FIVE -10.8%, CRWD -10.7% (also 4-for-1 stock split), VEEV -4.6%, DSGX -0.8%

Companies trading lower in after hours in reaction to news: ADCT -45.8% (topline data from its Phase 3 LOTIS-5 trial evaluating ZYNLONTA), DDD -15.2% (commences $40 mln stock offering), AEVA -11.1% (launches $100 mln follow-on public offering; files mixed shelf offering; also files for offering by selling shareholders), CUE -7.1% (stock offering by selling shareholders), JBIO -6.5% (stock offering), BTSG -4.4% (15 mln share offering and concurrent share repurchase), TAC -4.2% (TAC to acquire two gas assets in Colorado for $1 bln from BX and concurrent $350 mln bought deal offering), NEXT -1.5% (names new CFO), AVAV -0.8% (awarded a $117.3 mln Army contract), EL -0.6% (increases expected charge related to restructuring program), BX -0.1% (TAC to acquire two gas assets in Colorado for $1 bln from BX and concurrent $350 mln bought deal offering), DAR -0.1% (patent granted)

TheHill : House passes resolution to end Iran War, challenging Trump

House passes resolution to end Iran War, challenging Trump

House lawmakers on Wednesday passed legislation designed to force President Trump to end the Iran War, marking a victory for Democrats and the constitutional purists who say the conflict is illegal without explicit congressional approval.

The tally was 215-208, with four Republicans — Reps. Thomas Massie (Ky.), Brian Fitzpatrick (Pa.), Tom Barrett (Mich.) and Warren Davidson (Ohio) — joining every Democrat in supporting the measure.

The development is largely symbolic, since there are lingering disputes about whether the measure, known as a concurrent resolution, carries the force of law. And Trump is certain to contest the authority of the measure even if it’s also passed by the Senate, where it’s headed next.

Still, the vote represents a significant development in the political battle over the Iran War, putting Congress on the record condemning a conflict that has dragged on for more than three months — and rattled the global economy — with no clear end in sight.

“It’s very powerful,” said Rep. Jared Huffman (D-Calif.). “We’re inching closer to having both chambers of Congress declare this an illegal war. That’s huge.

“It’s just becoming more and more untenable, what he has done.”

The vote also highlights an increasing willingness among GOP lawmakers to buck Trump on prominent issues as the midterm election season evolves. Already, many Republicans are balking at Trump’s push for $1 billion for security surrounding his White House ballroom. And a wave of GOP opposition to Trump’s proposed $1.8 billion “weaponization” fund forced Trump officials to say this week that they’ve abandoned it altogether.

The war powers debate is fitting a similar mold.

War critics in both chambers have tried numerous times over the last three months to pass resolutions to end the war, only to have them blocked by Trump’s GOP allies. That changed last month when the Senate advanced its own war powers resolution after Sen. Bill Cassidy (R-La.) flipped his vote to yes just days after Trump helped to defeat Cassidy in Louisiana’s GOP primary. It’s unclear when the Senate measure will come up for a final vote.

In the House, Wednesday’s vote was the fourth time that critics of the war sought to end it. The first three war powers resolutions won some Republican support, but not enough to overcome the opposition of Trump’s allies in a chamber they control. Behind Speaker Mike Johnson (R-La.), most Republicans have argued that the conflict does not rise to the level of a war, and therefore doesn’t require congressional approval.

GOP leaders have also warned that tying Trump’s hands in the middle of the conflict would empower Tehran’s Islamic regime at the expense of American security.

The GOP’s wall of defense has eroded, however, as the conflict has grown increasingly unpopular nationally. The shift is not happening within the Republican base, who overwhelmingly support the war. But Independents have soured on conflict as it drags on — a warning sign for vulnerable Republicans fighting to keep their seats in November’s midterms.

A major factor in that shifting mood has been economic: the war has led directly to global trade disruptions that have spiked prices on domestic consumer staples like gas and some groceries, which have hit voters of all stripes. (While gas prices have ticked down over the last week, the national average for a gallon was $4.26 on Wednesday, up from $3.14 a year ago, according to the American Automobile Association.)

The increases have not been overlooked by Democrats in the Capitol, who have highlighted the issue at every opportunity to attack Trump for abandoning two of his chief pledges on the campaign trail: A promise to avoid conflicts overseas, and another to cut costs for working-class people.

“Donald Trump’s reckless and costly war of choice has cost everyday Americans hundreds, if not thousands of dollars more in increased costs, particularly as it relates to gas prices,” House Minority Leader Hakeem Jeffries (D-N.Y.) told reporters in the Capitol on Tuesday. “This war — this reckless and costly war of choice — needs to end today.”

Some Republicans have also pointed to the War Powers Act itself as a driving factor in their decision to support an end to the war. That 1973 law empowers presidents to launch military operations without congressional approval, in the name of national defense, for a specific window: 60 days, with the option to extend for another 30. That window closed in early May, leading some GOP lawmakers to demand that Trump come to Congress to approve the further use of military force against Tehran.

Sponsored by Rep. Greg Meeks (N.Y.), the senior Democrat on the House Foreign Affairs Committee, the resolution also leans heavily on the War Powers Act. Citing that law, it directs Trump to remove all U.S. forces “from hostilities” with Tehran “unless explicitly authorized by a declaration of war or a specific congressional authorization for use of military force against Iran.”

The resolution is designated as “concurrent,” meaning it will require approval from both chambers but does not go to the White House for the president’s signature or veto. That contrasts with the Senate’s war powers measure, a “joint” resolution, which would go to Trump’s desk and, if signed, carries the force of law. (Trump is expected to veto it if it gets that far).

The White House has dismissed the Meeks resolution on legal grounds, characterizing it as an “unconstitutional legislative veto” over executive authority. The administration is also challenging the measure from a practical angle, arguing that the conflict ended when Trump called for a ceasefire in early April.

“There are no present hostilities from which to remove U.S. Armed Forces,” the White House wrote last month in a formal document, known as a statement of administrative policy, opposing the Meeks bill. “The hostilities that began on February 28, 2026, have terminated with the ceasefire ordered by the President on April 7, 2026.”

In a separate vote on Wednesday, the House also advanced another piece of legislation opposed by the Trump administration: Aid for Ukraine amid the ongoing war with Russia. That bill was forced to the floor by an obscure procedural gambit, known as a discharge petition, which requires 218 signatures to compel votes on legislation opposed by the Republican leaders who control the chamber.

Last month, Rep. Kevin Kiley, a California Republican-turned-Independent, provided the 218th endorsement, forcing a vote later this week on an issue that has divided the House Republican conference.

TechCrunch : Alphabet’s record-breaking $85B raise for Google’s AI business is a

Alphabet’s record-breaking $85B raise for Google’s AI business is a helluva good signal

If Alphabet’s record-breaking $85 billion stock sale signals investor appetite for AI-related offerings — and it does — we can safely say that investors are voracious.

Google’s parent company had initially intended to sell a first tranche of $40 billion worth of various equity instruments — two different classes of shares, plus smaller “depositary shares” priced to be accessible to a broader range of investors. But the offering was so oversubscribed that it raised $45 billion instead, CEO Sundar Pichai said in a post on X on Monday. Among the buyers: Berkshire Hathaway, still known for its love of value investing, picked up $10 billion worth.

Alphabet plans to sell another $40 billion worth next quarter, for $85 billion total.

Even $80 billion would have topped the record for equity offerings previously set by Brazilian oil producer Petroleo Brasileiro SA, which raised $70 billion in 2010, Bloomberg reports.

Now, it’s true that these investors are buying shares of Alphabet, not shares in a younger, possibly debt-riddled AI startup. Alphabet is a very healthy business: $110 billion in revenue (with high profit margins) in Q1 alone, up 22% year-over-year.

Still, the money from this stock sale is earmarked for AI. “Part of our multi-year investment strategy to meet the AI opportunity ahead and support the demand we’re seeing from enterprises and consumers,” as Pichai described it. At Google I/O last month, he said the company expects to spend between $180 billion and $190 billion on capital expenditures — largely on AI infrastructure and data centers — before the year is out.

The timing matters beyond Alphabet itself. As Anthropic gets ready to go public, this enormously successful stock sale is a very good sign for the broader AI IPO pipeline. It indicates that public investors, particularly the deep-pocketed institutional ones, are ready to pony up.

The upcoming SpaceX IPO is expected to smash records for cash raised and valuation, and Anthropic’s deal is expected to do the same, possibly surpassing SpaceX. OpenAI is also waiting in the wings.

But all of this rests on public investors’ appetite — not just private VCs — remaining strong, and then staying that way. An unprecedented nearly $8 trillion in AI spending has been committed over the next five years. That money has to come from somewhere — and that somewhere includes individual company revenues, loans, and capital raised through stock sales. Whether public markets have the stomach to absorb that much, for that long, is the question that every AI company eyeing an IPO should be thinking about right now.

The Information : Nvidia Buys Enterprise Model-Maker Kumo AI for at Least $400 M

Nvidia Buys Enterprise Model-Maker Kumo AI for at Least $400 Million

The Takeaway
  • Nvidia acquires enterprise predictive AI startup Kumo AI for over $400 million.
  • Kumo AI specializes in predictive AI for enterprise structured data.
  • Acquisition expands Nvidia’s AI models optimized for its hardware.

Nvidia has bought Kumo AI, a five-year-old startup that sells predictive AI software to enterprises, for more than $400 million, said a person with knowledge of the deal.

The acquisition, first revealed by an Nvidia executive in a LinkedIn post on Tuesday, should expand Nvidia’s roster of AI models that can be optimized for Nvidia hardware and offered to enterprises for further customization.

Nvidia has invested heavily in its open-weight models, such as its Nemotron models, but Kumo’s models are proprietary. They’re tailored to answer questions on structured business data, such as customer information and payment data, which are generally harder for large language models to parse.

Kumo’s CEO and Nvidia declined to comment.

It’s unclear exactly how Nvidia will use Kumo’s models. It could use them in its AI Foundry software, which aims to help companies build custom AI models by combining their own data and domain-specific knowledge, such as genomic data, with Nvidia software, existing open-source models and synthetic, or AI-generated, data. Nvidia could also use Kumo’s researchers to help develop new, business-focused Nvidia foundation models.

Corporate data generally consists of structured layers of tables connected to other tables, and a company generally needs troves of proprietary data to train models on answering questions, such as on the likelihood that a customer will cancel. Kumo attempted to solve this problem by supplementing its training data with synthetic data from simulated enterprise environments and pairing that with graph machine learning techniques the founders developed at Stanford, the company has said.

Kumo released its latest model, KumoRFM-2, in April and says it counts DoorDash, Reddit, Databricks and Snowflake among its customers and partners. It raised $37 million from Sequoia Capital, Ron Conway’s SV Angel and others, including at a $250 million valuation in 2022, according to PitchBook.

Kumo founders Vanja Josifovski, former CTO of Pinterest; Jure Leskovec, a Stanford University professor, and Hema Raghavan, previously an AI lead at LinkedIn, have been working at Nvidia since May, according to their LinkedIn.

The Kumo deal is in line with Nvidia’s track record of smaller acquisitions. The company spent a total of around $3 billion on acquisitions over the last five years, according to its securities filings. Also, late last year it agreed to pay $20 billion to license technology from inference chip designer Groq,